Wills Eye Hospital is a renowned global leader in ophthalmology, with a history dating back to 1832. Based in Philadelphia, Pennsylvania, it stands as the #2 best hospital in the nation for ophthalmology, according to U.S. News & World Report 2014-2015 rankings. With a strong emphasis on clinical expertise, cutting-edge diagnostic testing, and advanced surgical capabilities, Wills Eye serves as a referral center for more than 250,000 patients annually. The hospital attracts patients from across the Philadelphia metropolitan area, the U.S., and worldwide, offering general eye care as well as comprehensive ophthalmic specialty services. Wills Eye continues to make significant contributions to the field of ophthalmology, owing to its dedicated and talented physicians and staff who are committed to enhancing and preserving sight. The hospital operates within the biotechnology and healthcare industries, positioning itself as a crucial player in the global ophthalmic care landscape. Currently, there is no publicly disclosed information regarding the last investment or the last investment investors for Wills Eye Hospital.
There is no investment information
No recent news or press coverage available for Wills Eye Hospital.